OT++ This is a listing of the search results from the WSJ site over the last 30 days. Find: Imclone
May. 4
TIP SHEET: Amerindo's Slattery Sees Mid-Cap Biotech Surge
Apr. 23
Technology Briefs
Allou Health & Beauty Care Inc. is expected to announce Friday the sale of a controlling stake in its online unit to an investor group for $37 million in cash and notes. The unit, Fragrance Counter, sells perfume and beauty products online. Allou, a Brentwood, N.Y., distributor of beauty and health-care products, launched its Internet business in 1995. The investor group includes style doyenne Martha Stewart, Allen & Co. managing director Nancy Peretsman, and Laurence Tisch's Loews Corp., according to people familiar with the transaction. Samuel Waksal, a venture capitalist and chief executive of ImClone Systems Inc., a New York biotechnology concern, leads the group. Allou is expected to retain a minority stake. America Online also will have a stake in the company through warrants it holds
Apr. 19
Research Reports
Apr. 15
SMARTMONEY DAILY SCREEN: Drug Stocks With Momentum
Apr. 14
ImClone Systems Cancer Pdt Trials Show Anti-Tumor Activity
Apr. 13
ImClone: Antibody Stops New Blood Vessel Growth In Tumors
One item, about the CEO, would hardy call for a stampede to IMCL stock. Although it is a quite pleasant to think that he is in business with Martha S. One is from SM Mag.(WSJ related) I had seen at least one other article on them. No real "new medical" stuff but the name was splashed around a bit. Waiting for the pull back.
Go BIOM!
Jim |
